mTOR is a crucial downstream signal of both RAS and RET pathways, and is aberrantly activated in NF1-deficient malignant peripheral nerve sheath tumours, phaeochromocytomas and paragangliomas (15). This evidence concerns the gene NF1 and paraganglioma.